Skip to main content

Table 1 Characteristics of control subjects and patients

From: Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease

 

Colonic biopsies

Ileal biopsies

 

Healthy controls

UC

inflamed

CD

inflamed

Healthy controls

CD

inflamed

N (Biopsy specimens)

13

12

15

16

16

Gender (male/female)

4/9

9/3

10/5

7/9

10/6

Age, yrs (mean, range)

55

(22-69)

38

(20-79)

30

(13-64)

51

(27-69)

32

(8-59)

Age at diagnosis

     

(A1, A2, A3)

 

1/8/3

4/9/2

 

5/8/3

Maximal location of disease

     

(L1, L2, L3)

  

0/3/12

 

5/0/11

(E1, E2, E3)

 

0/8/4

   

Maximal disease behavior

     

(B1, B2, B3)

  

8/5/2(6P)

 

9/5/2(5P)

Medication

     

   No

13

2

8

16

8

   5-aminosalicylates

 

3

1

 

4

   Corticosteroids

 

0

1

 

1

   Immunosuppressives

 

2

3

 

3

   Biologicals

 

0

1

 

0

   Combination

 

5

1

 

0

  1. Age at diagnosis; A1: 0-16 yrs, A2: 16-40 yrs, A3: >40 yrs. Maximal location of disease; CD; L1: solely ileal disease, L2: solely colonic disease, L3: ileal and colonic disease, UC; E1: ulcerative proctitis, E2: left-sided UC, E3: pancolitis. Maximal disease behavior; B1: non-stricturing, non-penetrating, B2: stricturing, B3: penetrating, (XP): number of patients when concomitant perianal disease was present.